Tech Company Financing Transactions
Regenesis Biomedical Funding Round
Regenesis Biomedical, operating out of Scottsdale, raised $300 thousand from Solstice Capital and private investors.
Transaction Overview
Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Investors
Solstice Capital (Harry George)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5301 N. Pima Rd.
Scottsdale, AZ 85250
USA
Scottsdale, AZ 85250
USA
Phone
Website
Email Address
Overview
Regenesis Biomedical, Inc. developed and markets the Provant Wound Therapy System, the exciting new scientifically proven approach that is redefining the care of soft tissue wounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Brooks
Chief Financial Officer
Dennis Genge
VP - Marketing
Scott Robey
VP - Sales
Thomas Eisiminger
Browse more venture capital transactions:
Prev: 3/31/2005: Integral Wave Technologies venture capital transaction
Next: 3/31/2005: Corepair venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs